Becton Dickinson boosts quarterly dividend

Becton Dickinson's ($BDX) board of directors boosted its quarterly dividend to 54.5 cents per common share, up 10% from the previous quarter. Lucky shareholders-of-record as of Dec. 10 get to reap the benefit on Dec. 31. That means the New Jersey maker of medical instruments and reagents will be hitting a $2.18 per share annual dividend for fiscal 2014. Becton Dickinson Chairman, CEO and President Vincent Forlenza noted in a statement that this is the 42nd consecutive year that the company raised its dividend. Becton Dickinson closed out its 2013 fiscal year with $2.1 billion in revenue during the fourth quarter, nearly 7% higher than the $2 billion booked during the same period last year. But the company's net income plunged due to its defeat in an antitrust civil trial. Item

Suggested Articles

Adaptive Biotechnologies is planning a $200 million IPO to help power its sequencing tests aimed at the body’s immune system and related therapies.

Abbott’s new diabetes test provides A1c results in three minutes, allowing clinicians to develop care plans within a single office visit.

Flatiron has hired a new chief medical officer as it looks to push on under its new parent in the world of electronic health records and real-world data.